Showing results (841-850 of 9,066) with videos related to
Sort By:
Pageof 907
Rheumatology (Oxford, England)|February 8, 2005
Patient-assessed health in ankylosing spondylitis: a structured reviewK L Haywood, A M Garratt, P T DawesRheumatology (Oxford, England)|February 8, 2005
An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytesK Migita, T Miyashita, Y Maeda, et al.Rheumatology (Oxford, England)|March 3, 2005
Beliefs about medications: a questionnaire survey of people with rheumatoid arthritisR Neame, A HammondRheumatology (Oxford, England)|March 3, 2005
TNF-blocking agents and tuberculosis: new drugs illuminate an old topicJ KeaneRheumatology (Oxford, England)|March 11, 2005
Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 yearsJ Braun, X Baraliakos, J Brandt, et al.Rheumatology (Oxford, England)|March 11, 2005
Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatmentS Wijngaarden, J A G van Roon, J G J van de Winkel, et al.Rheumatology (Oxford, England)|January 13, 2005
Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?S Ferreira, D P D'Cruz, G R V HughesRheumatology (Oxford, England)|February 25, 2005
Moderately intensive exercise in a temperate pool for patients with rheumatoid arthritis: a randomized controlled studyA Bilberg, M Ahlmén, K MannerkorpiRheumatology (Oxford, England)|June 2, 2005
Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trialR Sanmartí, S Marsal, J Valverde, et al.Rheumatology (Oxford, England)|June 2, 2005
Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic strokeT Kahles, M Humpich, H Steinmetz, et al.Pageof 907